2023
Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States
Swartwood N, Testa C, Cohen T, Marks S, Hill A, Beeler Asay G, Cochran J, Cranston K, Randall L, Tibbs A, Horsburgh C, Salomon J, Menzies N. Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States. BMC Medicine 2023, 21: 331. PMID: 37649031, PMCID: PMC10469407, DOI: 10.1186/s12916-023-02785-y.Peer-Reviewed Original ResearchConceptsLatent tuberculosis infectionTB outcomesDistrict of ColumbiaTreatment of LTBIIncremental cost-effectiveness ratioTB incidence rateTuberculosis disease burdenQuality-adjusted life yearsCost-effectiveness ratioPublic health agenciesTB casesTB preventionTB incidenceTuberculosis infectionTB epidemiologyDisease burdenIncidence rateService utilizationAdditional interventionsIncidence projectionsLife yearsDemographic dataSocietal perspectiveHealth agenciesPrevention approaches
2019
Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa
Marx F, Cohen T, Lombard C, Hesseling A, Dlamini S, Beyers N, Naidoo P. Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa. The International Journal Of Tuberculosis And Lung Disease 2019, 23: 891-899. PMID: 31533878, DOI: 10.5588/ijtld.18.0609.Peer-Reviewed Original ResearchConceptsSouth African health districtTB casesCase notification ratesHealth districtTB burdenNotification ratesHigh case notification ratesHIV co-infection rateHuman immunodeficiency virus (HIV) prevalenceTB case notification ratesAntenatal HIV prevalenceSecondary preventive therapyDrug-susceptible tuberculosisNew TB casesCo-infection rateTreatment history informationPreventive therapyMultivariable analysisHIV prevalenceSouth African districtPatient categoriesRelapseTuberculosisTreatment monitoringVirus prevalence